NEW

Medtronic Receives FDA Approval for Pipeline Flex Embolization Device with Shield Technology

Medtronic plc announced it has received approval from the United States Food and Drug Administration (FDA) for Pipeline Flex Embolization Device with Shield Technology.

CBET Announces Purdue Partnership at MD Expo

Purdue University is pairing its online courses to prepare health care professionals for the Certified Registered Central Service Technician exam with an externship program that gets them the 400 hours of experiential learning they must have to take the exam and become certified.

Avidicare Launches Opragon in a Box

Opragon In a Box is an all-in-one health care ventilation system that creates an ultra-clean zone for infection sensitive surgery.

EarthSafe Launches EvaClean Disposable Surface Disinfection Wipes

EarthSafe has enhanced its end-to-end infection prevention solution with the addition of the EvaClean Dry Wipes System.

Rosenberg Wins Samuel D. Gross Prize

Stephen A. Rosenberg, MD, Ph.D., is the Philadelphia Academy of Surgery’s 2020 Samuel D. Gross Prize winner. The prize is accompanied by a $5,000 monetary award and will be presented on November 2, 2020. Rosenberg was chosen by a panel of esteemed Philadelphia Academy of Surgery members.

Rosenberg is the chief, surgery branch, senior investigator, and head, tumor immunology section for the NIH, National Cancer Institute, Center for Cancer Research. He has pioneered the development of effective immunotherapies and gene therapies for patients with advanced cancers. His studies of the adoptive transfer of genetically modified lymphocytes have resulted in the regression of metastatic cancer in patients with melanoma, sarcomas and lymphomas.

Rosenberg’s current research is aimed at defining the host immune response of patients to their cancers. These studies emphasize the ability of human lymphocytes to recognize unique cancer antigens and the identification of anti-tumor T cell receptors that can be exploited to develop new cell transfer immunotherapies for the treatment of cancer patients.

As chief, Rosenberg also oversees the branch’s extensive clinical program aimed at translating scientific advances into effective immunotherapies for patients with cancer.

The Samuel D. Gross Prize was established by Samuel D. Gross (1805-1884), the founder of the Philadelphia Academy of Surgery. In his will, he provided $5,000 for a prize to be given every five years for the best original research in surgery by an American citizen.

“The Gross Prize is the oldest prize in the world for surgical research, preceding the Hunter Prize of the RCS, and the Flance-Karl Award of the American Surgical Association. It has a long reputation for ground-breaking work, including Dr. John Alexander’s first discussion in English on surgery for tuberculosis, Dr. Emile Holman’s first treatment of AV fistula, and Dr. Robert Elman’s parenteral alimentation,” says Dr. John R. Clarke, the 1983 Gross Prize winner and Executive Director Emeritus of the Philadelphia Academy of Surgery.

Recent Gross Prize recipients include Dr. N. Scott Adzick for fetal surgery in 2015, Dr. Anthony Atala for regenerative medicine in 2010, Dr. Thomas Starzl for liver transplantation in 2005, and Dr. Judah Folkman for angiogenesis in 2000.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X